• Patrick McCurry, Alicia Alexander Cadogan, Gudrun Hubinger, Sarah Paramour, Shu Tan, Viviane Minhoto Arid de Lima, Roopa Menon, and Dominick Albano.
• Global Medical Information, Pfizer Inc., New York, NY, USA.
• Curr Med Res Opin. 2023 Jul 1; 39 (7): 100710111007-1011.

AbstractMedical Information in the pharmaceutical industry involves the creation and dissemination of evidence-based scientific medical content in response to questions about medicines and therapy areas for patients and healthcare professionals. Health information equity can be broadly defined as the distribution of health information in a way that is accessible and understandable to all users, allowing them to benefit and reach their full potential for health. Ideally, this information would be made available to all those in need across the globe. However, as demonstrated by the COVID-19 pandemic, widespread health discrepancies exist. The World Health Organization defines health inequity as differences in health status or in the distribution of health resources between different population groups. Health inequities are influenced by the social conditions in which people are born, grow, live, work and age. This article explains select key factors influencing health information inequity and addresses opportunities where Medical Information departments can make a difference to improve global public health.

11 keywords...

hide…